Trial Profile
Development and a pilot study of the PACEPRO exercise and mood management program in depressed patients on escitalopram oxalate (Lexapro).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics; Therapeutic Use
- 03 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Aug 2011 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 30 Mar 2007 New trial record.